Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0000905148-25-000737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-18 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | +8,281 | 66.0K | +14% | $0 |
| DM | 2025-02-20 | 2025-02-18 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | -8,281 | 1,733 | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 770 | $0.00 | 69,113 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | M | A | 1,733 | $0.00 | 70,846 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-18 | M | A | 2,311 | $0.00 | 68,343 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-18 | M | A | 3,467 | $0.00 | 66,032 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-02-18 | M | D | 770 | $0.00 | 0 | D | $0.00 · — to — | 770 Common Stock | (F3) Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024. |
| 6 | Derivative | Restricted Stock Units | 2025-02-18 | M | D | 2,311 | $0.00 | 0 | D | $0.00 · — to — | 2,311 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024. |
| 7 | Derivative | Performance Stock Units | 2025-02-18 | M | D | 3,467 | $0.00 | 0 | D | $0.00 · — to — | 3,467 Common Stock | (F1) Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs. |
| 8 | Derivative | Restricted Stock Units | 2025-02-18 | M | D | 1,733 | $0.00 | 1,733 | D | $0.00 · — to — | 1,733 Common Stock | (F4) Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024. |